Target intelligence / Profile preview

Bacterial ribosomal protein and bacterial DNA

Molecular classification
Other (structural/ribosomal protein), Other (nucleic acid/genetic material)
01

Overview

Bacterial ribosomal proteins are structural and functional elements of the bacterial ribosome, essential for protein synthesis, and often involved in RNA-binding and ribosome assembly. They are vital for the translation machinery, forming complexes with rRNA to catalyze peptide bond formation and ensure accurate decoding of mRNA. Some ribosomal proteins also have regulatory or "moonlighting" functions beyond translation, including roles in gene expression and stress responses. Bacterial DNA is the genetic material of bacteria, encoding all proteins and regulatory elements required for cell function, and serves as the template for transcription and replication. Numerous antibiotics exploit differences between prokaryotic ribosomes and DNA-handling enzymes, selectively inhibiting bacterial growth without affecting human cells. Resistance typically arises from mutations in these molecular targets.

Other names
ribosomal proteinr-proteinribosomal subunit protein30S subunit protein50S subunit proteindeoxyribonucleic acidbacterial genomic DNAchromosomal DNA
02

Mechanism of action

Ribosomal protein inhibitors: Inhibit bacterial translation, either by binding to ribosomal RNA or proteins in the 30S or 50S subunit, disrupting decoding, peptide bond formation, or translocation. DNA-targeting drugs: Inhibit DNA replication or integrity (e.g., by interfering with DNA gyrase/topoisomerase, causing DNA strand breaks, or blocking transcription)

03

Biological functions

protein synthesis/translationribosome assemblyextra-ribosomal regulatory rolesregulation of gene expressionRNA–protein and protein–protein interactionsgenetic information storage and transmissiontemplate for transcription and replication
04

Disease associations

Infection
05

Safety considerations

Off-target toxicity (especially for drugs with partial activity on human mitochondrial ribosomes or DNA)Antimicrobial resistance (due to mutation or acquisition of resistance genes)Adverse effects specific to each drug class (e.g., nephrotoxicity for aminoglycosides, tendinopathy for fluoroquinolones)
06

Interacting drugs

aminoglycosides (e.g., gentamicin, streptomycin)

8 more in the full profile.

07

Biomarkers

Mutations in ribosomal proteins or rRNA (e.g., rpsL mutations for aminoglycoside resistance, 23S rRNA mutations for macrolide resistance)Mutations in DNA gyrase/topoisomerase genes (for fluoroquinolone resistance)

Beyond the preview

Go deeper on Bacterial ribosomal protein and bacterial DNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial ribosomal protein and bacterial DNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call